Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lake

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Human Molecular Genetics|December 5, 2006
Sex-specific linkage to total serum immunoglobulin E in families of children with asthma in Costa RicaBenjamin A Raby, Manuel E Soto-Quiros, Lydiana Avila, et al.
Neurology|September 4, 2016
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MSDouglas L Arnold, Elizabeth Fisher, Vesna V Brinar, et al.
Journal of Animal Science|August 9, 2012
Determination of the appropriate delivery of prostaglandin F2α in the five-day CO-Synch + controlled intravaginal drug release protocol in suckled beef cowsG A Bridges, J K Ahola, C Brauner, et al.
Water|August 7, 2018
Performance of National Maps of Watershed Integrity at Watershed ScalesAnne Kuhn, Scott G Leibowitz, Zachary C Johnson, et al.
Pigment Cell & Melanoma Research|January 24, 2019
Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcomeNihal Kenawy, Helen Kalirai, Joseph J Sacco, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialAlasdair J Coles, Cary L Twyman, Douglas L Arnold, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Animal Reproduction Science|January 31, 2021
Pre-synchronization of ovulation timing and delayed fixed-time artificial insemination increases pregnancy rates when sex-sorted semen is used for insemination of heifersN Oosthuizen, P L P Fontes, R V Oliveira Filho, et al.
American Journal of Human Genetics|December 17, 2005
The SERPINE2 gene is associated with chronic obstructive pulmonary diseaseDawn L Demeo, Thomas J Mariani, Christoph Lange, et al.
The New England Journal of Medicine|April 16, 2010
A randomized study of alglucosidase alfa in late-onset Pompe's diseaseAns T van der Ploeg, Paula R Clemens, Deyanira Corzo, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Human Molecular Genetics|December 5, 2006
Sex-specific linkage to total serum immunoglobulin E in families of children with asthma in Costa RicaBenjamin A Raby, Manuel E Soto-Quiros, Lydiana Avila, et al.
Neurology|September 4, 2016
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MSDouglas L Arnold, Elizabeth Fisher, Vesna V Brinar, et al.
Journal of Animal Science|August 9, 2012
Determination of the appropriate delivery of prostaglandin F2α in the five-day CO-Synch + controlled intravaginal drug release protocol in suckled beef cowsG A Bridges, J K Ahola, C Brauner, et al.
Water|August 7, 2018
Performance of National Maps of Watershed Integrity at Watershed ScalesAnne Kuhn, Scott G Leibowitz, Zachary C Johnson, et al.
Pigment Cell & Melanoma Research|January 24, 2019
Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcomeNihal Kenawy, Helen Kalirai, Joseph J Sacco, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialAlasdair J Coles, Cary L Twyman, Douglas L Arnold, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Animal Reproduction Science|January 31, 2021
Pre-synchronization of ovulation timing and delayed fixed-time artificial insemination increases pregnancy rates when sex-sorted semen is used for insemination of heifersN Oosthuizen, P L P Fontes, R V Oliveira Filho, et al.
American Journal of Human Genetics|December 17, 2005
The SERPINE2 gene is associated with chronic obstructive pulmonary diseaseDawn L Demeo, Thomas J Mariani, Christoph Lange, et al.
The New England Journal of Medicine|April 16, 2010
A randomized study of alglucosidase alfa in late-onset Pompe's diseaseAns T van der Ploeg, Paula R Clemens, Deyanira Corzo, et al.
Pageof 18